• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

genomics data

Labcorp and Ultima Genomic Partner to Advance Whole Genome Sequencing for Cancer Research

by Syed Hamza Sohail 07/31/2024 Leave a Comment

Labcorp and Ultima Genomics Partner to Advance Whole Genome Sequencing for Cancer Research

What You Should Know: -   Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing (WGS) clinical applications, including molecular residual disease (MRD) in patients with early-stage solid tumor cancers. -  Labcorp recently introduced Labcorp® Plasma Detect™, the first clinically validated,
Read More

Cone Health, Helix Launches 5-Year Population Genomics Testing Initiative

by Fred Pennic 11/09/2023 Leave a Comment

Cone Health, Helix Launches 5-Year Population Genomics Testing Initiative

What You Should Know: - Cone Health, a non-profit healthcare network in North Carolina, and Helix, a population genomics company, have partnered to launch a five-year research study that will enroll and track 100,000 healthy people. - The study will use Helix's population genomics platform to provide medical insights for Cone Health patients and help identify people at risk for certain diseases and conditions. Study Enrollment & Benefits Enrollment in the program is optional and
Read More

Sema4, BioSymetrics Partner to Advance Data-Driven Drug Discovery

by Jasmine Pennic 02/22/2022 Leave a Comment

Mount Sinai Spinout Sema4 Launches to Revolutionize Clinical Diagnostics

What You Should Know: - Today, Sema4, a leader in AI-driven clinical data intelligence, announced that they have partnered with BioSymetrics, to accelerate the advancement of drug discovery and new treatments for patients and pharmaceutical companies. - Together the two will leverage Sema4’s Centrellis®, one of the largest and fastest-growing integrated health information platforms that includes approximately 12 million de-identified clinical records, and Elion, BioSymetrics’
Read More

Raising the Bar for COVID-19 Data Integrity and Disease Surveillance

by Seth Hirsch, COO, SES Corporation 09/14/2020 Leave a Comment

Raising the Bar for COVID-19 Data Integrity and Disease Surveillance

Just a few weeks ago, the mood among technologists in the Coronavirus pandemic remained cautiously optimistic about reopening society with the help of testing data, contact tracing apps, and other IT-enabled resources.  But the recent spike in illness – 1.9 million new US cases in July, more than double any other month – is a sobering reboot on a crisis we now understand needs far more IT and data coordination than previously recognized.  The emerging consensus among epidemiologists is that
Read More

LunaPBC Raises $4.6M to Fuel Community-Owned Genomic & Health Data Platform

by Fred Pennic 05/08/2019 Leave a Comment

LunaPBC Raises $4.6M to Fuel Community-Owned Genomic & Health Data Platform

LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, has raised $4.6 million from ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners. The latest round brings the company’s total funding to date to $7.6 million. First Community-Owned Health & DNA Research Platform Founded in 2017 on the belief that health data sharing and community ownership are the new philanthropy, LunaDNA is the first
Read More

7 Trends Accelerating “TechBio” – The Life Sciences and Computer Sciences Convergence

by Vasudev Bailey, Ph.D., Partner at ARTIS Ventures 05/01/2019 Leave a Comment

We are now living in what I’m calling the TechBio revolution. That’s not a typo that should read BioTech, but rather a new way of looking at the convergence of technology and biology. TechBio is defined as an engineering-first approach of biological processes for industrial, and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, and so on. A process that uses AI and data-enabled discovery to complement the exploration of
Read More

5 Ways SmartTrials is Advancing Precision Medicine Through Genomics

by Erica Garvin 06/04/2018 Leave a Comment

5 Ways SmartTrials is Advancing Precision Medicine Through Genomics

 Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More

Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers

by Fred Pennic 05/15/2018 Leave a Comment

Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers

Genoox, a genomic analysis startup making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications has announced a $6 million investment today, led by Triventures and joined by Inimiti Capital Partners and Glilot Capital Partners. Genetic analysis takes other systems hours, but takes Genoox minutes, enabling clinical genomics to become available to millions who don’t have access to top 10 academic centers.Founded
Read More

Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database

by Fred Pennic 05/09/2018 Leave a Comment

Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database

Luna DNA, the first community-owned genomic and medical research database has raised $4 million in funding from lead investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader of the Human Genome Project and current advisor to Luna DNA. The startup plans to use the funds to support the next phase in creating Luna’s research platform and engaging a global community
Read More

Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market

by HITC Staff 07/11/2017 Leave a Comment

Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market

Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |